| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014976902 |
| P356 | DOI | 10.1038/350512A0 |
| P953 | full work available at URL | http://www.nature.com/articles/350512a0 |
| http://www.nature.com/articles/350512a0.pdf | ||
| P3181 | OpenCitations bibliographic resource ID | 615416 |
| P698 | PubMed publication ID | 1826542 |
| P50 | author | Harald Jüppner | Q103034311 |
| Theodora Bloom | Q43250504 | ||
| P2093 | author name string | H G Kim | |
| Kronenberg HM | |||
| Kim HG | |||
| H M Kronenberg | |||
| Ruderman JV | |||
| Arnold A | |||
| J V Ruderman | |||
| Motokura T | |||
| P2860 | cites work | Genetic abnormalities in sporadic parathyroid adenomas | Q68531469 |
| Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF | Q69333828 | ||
| Protein-DNA interactions in vivo upstream of a cell cycle-regulated human H4 histone gene | Q22254868 | ||
| DAF1, a mutant gene affecting size control, pheromone arrest, and cell cycle kinetics of Saccharomyces cerevisiae | Q24627252 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| A comprehensive set of sequence analysis programs for the VAX | Q26778432 | ||
| Use of T7 RNA polymerase to direct expression of cloned genes | Q27860692 | ||
| Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2 | Q28257603 | ||
| Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division | Q28261164 | ||
| Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation | Q28270848 | ||
| Universal control mechanism regulating onset of M-phase | Q29616481 | ||
| Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma | Q33493133 | ||
| The A- and B-type cyclin associated cdc2 kinases in Xenopus turn on and off at different times in the cell cycle. | Q33921443 | ||
| Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. | Q34173355 | ||
| Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma | Q34575421 | ||
| The role of cyclin B in meiosis I. | Q36220481 | ||
| Control of programmed cyclin destruction in a cell-free system | Q36221788 | ||
| Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle | Q36937872 | ||
| Cooperation between oncogenes | Q37625799 | ||
| FAR-reaching discoveries about the regulation of START. | Q38012138 | ||
| Dominoes and clocks: the union of two views of the cell cycle | Q38718174 | ||
| The clam embryo protein cyclin A induces entry into M phase and the resumption of meiosis in Xenopus oocytes | Q48354406 | ||
| Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas | Q68270144 | ||
| Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer | Q68420205 | ||
| P433 | issue | 6318 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 512-5 | |
| P577 | publication date | 1991-04-11 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | A novel cyclin encoded by a bcl1-linked candidate oncogene | |
| P478 | volume | 350 |
| Q71683670 | 11q13 amplification in local recurrence of human primary breast cancer |
| Q78164151 | 11q13 is a cytogenetically promiscuous site in hematologic malignancies |
| Q77652370 | 5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia |
| Q34541728 | 8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma |
| Q24628598 | A 3-Mb contig from D11S987 to MLK3, a gene-rich region in 11q13 |
| Q74570961 | A case of t(8;14) with total and partial trisomy 3 in Waldenstrom macroglobulinemia |
| Q28294586 | A central domain of cyclin D1 mediates nuclear receptor corepressor activity |
| Q70463530 | A closer look at the cell cycle |
| Q33784966 | A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus |
| Q36697844 | A family of cyclin D homologs from plants differentially controlled by growth regulators and containing the conserved retinoblastoma protein interaction motif. |
| Q24300226 | A family of human cdc2-related protein kinases |
| Q34044533 | A growing role for Rho family GTPases as intermediaries in growth factor- and adhesion-dependent cell cycle progression |
| Q28272347 | A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers |
| Q40957310 | A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation. |
| Q27931253 | A new pair of B-type cyclins from Saccharomyces cerevisiae that function early in the cell cycle |
| Q59647763 | A novel bcl-1/JH breakpoint from a patient affected by mantle cell lymphoma extends the major translocation cluster |
| Q36654228 | A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells |
| Q74297344 | A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma |
| Q33997396 | A specific role for cyclin D1 in mammary gland development |
| Q40794525 | A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT. |
| Q41893268 | ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis |
| Q35094511 | Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis |
| Q41483751 | Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system |
| Q24561670 | Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26 |
| Q53354181 | Activation of STAT 5-cyclin D1 pathway in chewing tobacco mediated oral squamous cell carcinoma. |
| Q47670094 | Activation of cyclin D1 expression by the ERK5 cascade |
| Q40241034 | Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle |
| Q35753340 | Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas |
| Q41118589 | Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation |
| Q74570971 | Acute myeloid leukemia with a novel (7;11)(q36;q13) translocation |
| Q42105577 | Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome |
| Q36931408 | Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins |
| Q28216902 | Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas |
| Q47820459 | Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. |
| Q36815171 | Altered chromosome 6 in immortal human fibroblasts |
| Q36567970 | Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer |
| Q53443477 | Altered gene expression in spontaneous hepatocellular carcinomas from male B6C3F1 mice. |
| Q33858149 | Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells. |
| Q40027619 | Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration |
| Q36847675 | Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas |
| Q40848979 | Amplification and overexpression of the cyclin D1 gene in head and neck squamous cell carcinoma |
| Q28298048 | Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1 |
| Q24301656 | An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling |
| Q34374920 | An acidic environment changes cyclin D1 localization and alters colony forming ability in gliomas |
| Q37366017 | An evolutionarily conserved cyclin homolog from Drosophila rescues yeast deficient in G1 cyclins. |
| Q37903910 | An overview of the molecular pathology of head and neck cancer, and its clinical implications. |
| Q38782834 | An update on the implications of cyclin D1 in oral carcinogenesis. |
| Q38508135 | Analysis of 14q+ derivative chromosomes in non-Hodgkin's lymphomas by fluorescence in-situ hybridization |
| Q42599044 | Analysis of nucleotide sequence of the rightmost 43 kbp of herpesvirus saimiri (HVS) L-DNA: General conservation of genetic organization between HVS and Epstein-Barr virus |
| Q55387322 | Analysis of oncogenes and tumor suppressor genes in human breast cancer. |
| Q74453843 | Analysis of the Cycilin D1/p16/pRb Pathway in Parathyroid Adenomas |
| Q38089204 | Animal models of hyperfunctioning parathyroid diseases for drug development |
| Q37017116 | Annotating cancer variants and anti-cancer therapeutics in reactome |
| Q41501630 | Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells |
| Q28611432 | Apoptosis, cancer and the p53 tumour suppressor gene |
| Q47884017 | Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas |
| Q70806593 | Assessing sequential oncogene amplification in human breast cancer |
| Q77170015 | Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma |
| Q78828654 | BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance |
| Q38708855 | Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma |
| Q41273184 | Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines |
| Q53403656 | Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer. |
| Q84157533 | CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis |
| Q34583855 | CCND1 gene polymorphic variants in patients with differentiated thyroid carcinoma |
| Q30736574 | CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle |
| Q46638622 | Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes |
| Q34464170 | Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53. |
| Q49544319 | Cell Cycle Regulation in Treatment of Breast Cancer. |
| Q43674653 | Cell biology. Cell cycle gets more cyclins |
| Q33895864 | Cell cycle control and cancer |
| Q35346242 | Cell cycle control in normal and neoplastic cells |
| Q33608768 | Cell cycle control, checkpoint mechanisms, and genotoxic stress |
| Q34841110 | Cell cycle controls: potential targets for chemical carcinogens? |
| Q34720567 | Cell cycle dysregulation in oral cancer |
| Q36060004 | Cell cycle regulation and its aberrations in human lung carcinoma |
| Q28610294 | Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15 |
| Q36560592 | Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. |
| Q34445149 | Cell cycle regulation of the p34cdc2 inhibitory kinases |
| Q40529953 | Cell cycle regulators in the keratinocyte (cyclin-cdk). |
| Q40514881 | Cell-cycle regulators and cancer |
| Q72168972 | Changes of G1 cyclins, cdk2, and cyclin A during the differentiation of HL60 cells induced by TPA |
| Q40541025 | Characterization of a 14q+ marker chromosome in philadelphia chromosome positive acute lymphoblastic leukemia by DNA analysis and fluorescence in situ hybridization |
| Q24596448 | Characterization of a candidate bcl-1 gene |
| Q37317141 | Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer |
| Q38502017 | Characterization of recurrent homogeneously staining regions in 72 breast carcinomas |
| Q34235181 | Checkpoint genes in cancer. |
| Q42516093 | Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice |
| Q33647909 | Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32). |
| Q40524872 | Chromosome 11q13 markers and D-type cyclins in breast cancer |
| Q42741021 | Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism |
| Q55266713 | Circadian locomotor output cycles kaput affects the proliferation and migration of breast cancer cells by regulating the expression of E-cadherin via IQ motif containing GTPase activating protein 1. |
| Q36431072 | Classical gene amplifications in human breast cancer are not associated with distant solid metastases |
| Q34125668 | Clinical and molecular genetics of parathyroid neoplasms |
| Q93911725 | Clinical implications of molecular and cytogenetic studies of non-Hodgkin's lymphomas |
| Q45967471 | Clinical profile of primary hyperparathyroidism in adolescents and young adults. |
| Q35601767 | Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe |
| Q36902600 | Cloning of a D-type cyclin from murine erythroleukemia cells |
| Q36292810 | Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro |
| Q51042797 | Complete genomic landscape of a recurring sporadic parathyroid carcinoma. |
| Q37641907 | Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas |
| Q35210567 | Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations |
| Q40594377 | Control of cell proliferation during plant development |
| Q33367607 | Control of root growth and development by cyclin expression. |
| Q40531120 | Control of the cell cycle |
| Q68088862 | Controversies and advances in primary hyperparathyroidism |
| Q37640655 | Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer |
| Q24329048 | Cyclin A is required at two points in the human cell cycle |
| Q37132604 | Cyclin A, cell cycle control and oncogenesis |
| Q31107812 | Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells. |
| Q40886474 | Cyclin D and oncogenesis |
| Q35833787 | Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia |
| Q73145251 | Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancers |
| Q30464217 | Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase π gene expression in head and neck squamous cell carcinoma |
| Q47975825 | Cyclin D1 and Cyclin E expression in malignant thyroid cells and in human thyroid carcinomas |
| Q40959992 | Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer |
| Q40794379 | Cyclin D1 and human neoplasia |
| Q24796232 | Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models |
| Q74116625 | Cyclin D1 and retinoblastoma protein expression in Kaposi's sarcoma |
| Q28295915 | Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription |
| Q28294725 | Cyclin D1 determines estrogen signaling in the mammary gland in vivo |
| Q33877550 | Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression |
| Q37228185 | Cyclin D1 expression and HHV8 in Kaposi sarcoma |
| Q80342451 | Cyclin D1 expression and cervical metastases in squamous cell carcinoma of the mouth |
| Q77384616 | Cyclin D1 expression as a prognostic factor in advanced hypopharyngeal carcinoma |
| Q35764646 | Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. |
| Q36617988 | Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome |
| Q38379182 | Cyclin D1 expression is correlated with cell differentiation and cell proliferation in oral squamous cell carcinomas |
| Q35145847 | Cyclin D1 expression is regulated by the retinoblastoma protein |
| Q73745059 | Cyclin D1 expression is useful as a prognostic indicator for advanced esophageal carcinomas, but not for superficial tumors |
| Q47817903 | Cyclin D1 gene amplification in esophageal carcinosarcoma shown by differential polymerase chain reaction |
| Q73267965 | Cyclin D1 genotype in areca-associated oral squamous cell carcinoma |
| Q37698862 | Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone Regulation |
| Q35677993 | Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle |
| Q28235209 | Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment |
| Q36550924 | Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. |
| Q55169980 | Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies. |
| Q36294947 | Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma |
| Q35666693 | Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer |
| Q35788347 | Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck |
| Q73662616 | Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas |
| Q41493003 | Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling |
| Q42801826 | Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation |
| Q37631754 | Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene |
| Q36559825 | Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit |
| Q41578764 | Cyclin D1/PRAD1 as a central target in oncogenesis |
| Q40792693 | Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. |
| Q28303053 | Cyclin D1: polymorphism, aberrant splicing and cancer risk |
| Q40806544 | Cyclin D2 and Ha-Ras transformed rat embryo fibroblasts exhibit a novel deregulation of cell size control and early S phase arrest in low serum |
| Q59102116 | Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development |
| Q59102120 | Cyclin D3 Compensates for Loss of Cyclin D2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD40 |
| Q53543241 | Cyclin Dl expression in B-cell non Hodgkin lymphoma. |
| Q36136157 | Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status |
| Q24309263 | Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression |
| Q44752373 | Cyclin a is required for the onset of DNA replication in mammalian fibroblasts |
| Q35550165 | Cyclin alterations in diverse cancers: Outcome and co-amplification network |
| Q43005996 | Cyclin d1 induces chromosomal instability |
| Q38038670 | Cyclin-dependent kinase modulators and cancer therapy |
| Q37355981 | CyclinD1, a prominent prognostic marker for endometrial diseases |
| Q72674719 | Cyclins and cancer: wheels within wheels |
| Q28611449 | Cyclins and cyclin-dependent kinases: a biochemical view |
| Q40551569 | Cyclins and cyclin-dependent kinases: theme and variations |
| Q38497524 | Cytogenetic analysis of non Hodgkin's lymphomas by ratio-painting and comparative genomic hybridization reveals unsuspected chromosomal abnormalities |
| Q27690967 | D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells |
| Q29614966 | D-type cyclin-dependent kinase activity in mammalian cells |
| Q36234063 | DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 |
| Q73114505 | Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma |
| Q35842080 | Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas |
| Q24545945 | Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice |
| Q40963456 | Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction |
| Q30867713 | Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas |
| Q73711207 | Development of intermediate-grade (mantle cell) and low-grade (small lymphocytic and marginal zone) human non-Hodgkin's lymphomas xenotransplanted in severe combined immunodeficiency mouse models |
| Q41271543 | Different Regulation of the Human Thymidine Kinase Promoter in Normal Human Diploid IMR-90 Fibroblasts and HeLa Cells |
| Q70937769 | Different expression patterns of cyclins A, D1 and E in human colorectal cancer |
| Q41500328 | Differential diagnosis, causes, and management of hypercalcemia |
| Q49015677 | Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo. |
| Q54633731 | Differential expression of proteins regulating cell cycle progression in growth vs. differentiation. |
| Q71825030 | Differential regulation of the synthesis and activity of the major cyclin‐dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes |
| Q39877438 | Differential tumorigenicity between Epstein-Barr virus genome-positive and genome-negative cell lines with t(11;14)(q13;q32) derived from mantle cell lymphoma |
| Q40957469 | Diminished G1 checkpoint after gamma-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpression |
| Q47996361 | Distinct cyclin D genes show mitotic accumulation or constant levels of transcripts in tobacco bright yellow-2 cells |
| Q41403912 | Distinct patterns of expression of the D-type cyclins during testicular development in the mouse |
| Q24293575 | Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro |
| Q40811164 | Ectopic expression of cyclin D1 impairs the proliferation and enhances the apoptosis of a murine lymphoid cell line. |
| Q41450893 | Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators |
| Q40385219 | Effects of exogenous wild-type P16 gene transfection on the expression of cell cycle-related proteins in bladder cancer cell line |
| Q41003401 | Effects of targeted silencing of FOXC1 gene on proliferation and in vitro migration of human non-small-cell lung carcinoma cells |
| Q36827075 | Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E |
| Q34435745 | Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes |
| Q36853438 | Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. |
| Q73662909 | Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer |
| Q34621876 | Epidermal growth factor receptor gene copy number aberration at the primary tumour is significantly associated with extracapsular spread in oral cancer |
| Q33828576 | Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1. |
| Q44126746 | ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1. |
| Q33191675 | Establishment of a highly sensitive and specific exon-trapping system |
| Q36539618 | Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism |
| Q35174152 | Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma |
| Q28297345 | Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels |
| Q50850441 | Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma. |
| Q52834054 | Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. |
| Q77933504 | Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence |
| Q36641066 | Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells |
| Q54986217 | Expression of G1-->S transition regulatory molecules in human urothelial cancer. |
| Q74624181 | Expression of PRAD1/cyclin D1 in plasma cell malignancy: incidence and prognostic aspects |
| Q71869760 | Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors |
| Q36431722 | Expression of cyclin D1 correlates with malignancy in human ovarian tumours |
| Q37429299 | Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia |
| Q71988957 | Expression of proliferation-associated antigens (PCNA, p120, p145) during the reentry of G0 cells into the cell cycle |
| Q35773697 | Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity |
| Q35306247 | Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma |
| Q31919175 | Expressional changes in alternative splicing affecting genes during cell passage of human diploid fibroblasts |
| Q39766173 | FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines |
| Q35229559 | Five FGF receptors with distinct expression patterns |
| Q37316601 | Following the cytokine signaling pathway to leukemogenesis: a chronology |
| Q77711537 | Frequency and prognostic relevance of cyclin D1 dysregulation in multiple myeloma |
| Q41332206 | Frequent amplification of the cyclin E gene in human gastric carcinomas |
| Q40402300 | Frequent loss of chromosome arm 1p DNA in parathyroid adenomas |
| Q35906984 | From chemoprevention to chemotherapy: common targets and common goals |
| Q34994859 | Function of a human cyclin gene as an oncogene |
| Q78348035 | Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development |
| Q28277731 | Functional analysis of the human cyclin D2 and cyclin D3 promoters |
| Q40965316 | Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells |
| Q41616468 | Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line |
| Q41421665 | G1 cyclins and control of the cell division cycle in normal and transformed cells |
| Q36530627 | G1/S control of anchorage-independent growth in the fibroblast cell cycle |
| Q40302213 | Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation |
| Q35184458 | Gamma herpesviruses: pathogenesis of infection and cell signaling |
| Q39035786 | Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis |
| Q40291449 | Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. |
| Q49229625 | Gene amplifications in advanced-stage human prostate cancer. |
| Q40972502 | Genetic alterations in breast cancer. |
| Q28285050 | Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer |
| Q27025359 | Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors |
| Q85966775 | Genetic association between cyclin D1 polymorphism and breast cancer susceptibility |
| Q35697802 | Genetic reevaluation of the role of F-box proteins in cyclin D1 degradation |
| Q33714058 | Genetic replacement of cyclin D1 function in mouse development by cyclin D2. |
| Q45359916 | Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population |
| Q39286328 | Genetics of Hyperparathyroidism, Including Parathyroid Cancer |
| Q41136743 | Genetics of colorectal and breast cancer. |
| Q35668788 | Genetics of endocrine and metabolic disorders: parathyroid |
| Q40975265 | Genetics of follicular thyroid cancer. |
| Q28212569 | Genomic organization of the human folate receptor genes on chromosome 11q13 |
| Q37783548 | Genomic profiles in B cell lymphoma |
| Q30360213 | Genomic profiling reveals mutational landscape in parathyroid carcinomas |
| Q91677972 | Glycosylation and metastases |
| Q71804549 | Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: potential early indicators of treatment response |
| Q41028226 | Growth arrest associated with 12-o-tetradecanoylphorbol-13-acetate-induced hematopoietic differentiation with a defective retinoblastoma tumor suppressor-mediated pathway |
| Q40241821 | Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms |
| Q36686536 | Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression |
| Q24317567 | Growth suppression by p16ink4 requires functional retinoblastoma protein |
| Q37257805 | Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts |
| Q38306079 | HSNF5/INI1 gene mutations in lymphoid malignancy |
| Q34293483 | HTLV-I Tax related dysfunction of cell cycle regulators and oncogenesis of adult T cell leukemia |
| Q40507756 | Haellpolymorphism within 3′ untranslated region of PRAD1 |
| Q78156233 | Hairy cell leukemia with translocation (11;20)(q13;q11) and overexpression of cyclin D1 |
| Q39520921 | Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells |
| Q24672747 | Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31 |
| Q43566357 | Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins |
| Q40901633 | Human B cell lymphomas: in vitro and in vivo studies on growth factors and cell growth. |
| Q28268832 | Human D-type cyclin |
| Q33774432 | Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb |
| Q24652527 | Human cyclin E, a nuclear protein essential for the G1-to-S phase transition |
| Q24568186 | Human cyclin F |
| Q36923077 | Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. |
| Q28612313 | Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport |
| Q34733433 | Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance. |
| Q44639159 | IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1phase cell cycle proteins |
| Q71376540 | INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes |
| Q24324587 | Identification of G1 kinase activity for cdk6, a novel cyclin D partner |
| Q73359146 | Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples |
| Q31676720 | Identification of the E2A gene products as regulatory targets of the G1 cyclin-dependent kinases |
| Q37374902 | Identification of the domains in cyclin A required for binding to, and activation of, p34cdc2 and p32cdk2 protein kinase subunits |
| Q28278623 | Identification of the p28 subunit of eukaryotic initiation factor 3(eIF3k) as a new interaction partner of cyclin D3 |
| Q42181500 | Identifying gastric cancer related genes using the shortest path algorithm and protein-protein interaction network. |
| Q55026872 | Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. |
| Q35810205 | Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). |
| Q72566051 | Immunohistochemical detection of cyclin D and cyclin A in human hyperproliferative epidermis |
| Q38477902 | Immunohistochemistry of cyclin D3 in pulmonary carcinomas |
| Q43701627 | In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53. |
| Q41901560 | Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue |
| Q35844125 | Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process |
| Q41184054 | Infrequent alterations of the p16INK4A gene in liver cancer |
| Q77679664 | Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1 |
| Q33773323 | Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. |
| Q36710873 | Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1 |
| Q34167898 | Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNA |
| Q34012822 | Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation |
| Q28374702 | Inhibitory effect of mimosine on proliferation of human lung cancer cells is mediated by multiple mechanisms |
| Q44490328 | Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide |
| Q33643327 | Insights into cancer from transgenic mouse models |
| Q36776958 | Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells |
| Q47835152 | Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomas |
| Q35250316 | Investigating breast cancer cell behavior using tissue engineering scaffolds |
| Q40901594 | Is the working formulation adequate for the classification of the low grade lymphomas? |
| Q36796845 | Isolation of Drosophila cyclin D, a protein expressed in the morphogenetic furrow before entry into S phase. |
| Q28272102 | Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast |
| Q35872949 | Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma |
| Q39878517 | Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. |
| Q33671160 | Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology |
| Q34475001 | Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis |
| Q36333774 | Learning about cancer genes through invertebrate genetics. |
| Q36708288 | Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): a subtype of mantle cell lymphoma? |
| Q57279394 | Leukemic involvement is a common feature in mantle cell lymphoma |
| Q41622053 | Linkage map of a region of human chromosome band 11q13 amplified in breast and squamous cell tumors |
| Q35012861 | Linking cyclins to transcriptional control. |
| Q47672507 | Liver regeneration, liver cancers and cyclins |
| Q28243147 | Localization of the expressed human p58 protein kinase chromosomal gene to chromosome 1p36 and a highly related sequence to chromosome 15 |
| Q35975697 | Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer |
| Q40717073 | Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma |
| Q36796448 | Mammalian interphase cdks: dispensable master regulators of the cell cycle |
| Q34342812 | Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice |
| Q55240879 | Mantle cell lymphoma with the features of mucosa-associated lymphoid tissue (MALT) lymphoma in an HTLV-I-seropositive patient. |
| Q35663027 | Mantle cell lymphoma: an update |
| Q53356360 | Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. |
| Q30452448 | Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop |
| Q41042080 | Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression |
| Q34224865 | Mechanisms of action of flavopiridol |
| Q34119143 | Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery |
| Q34776998 | Mechanisms of secondary hyperparathyroidism |
| Q29616203 | Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors |
| Q34575813 | MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. |
| Q34987420 | Molecular alterations in sporadic breast cancer |
| Q40917320 | Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants |
| Q41140205 | Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis |
| Q38478886 | Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines |
| Q72013090 | Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma |
| Q41200046 | Molecular characterization of an unusual non-Hodgkin's B-lymphoma cell line ("Farage") lacking the ability to produce immunoglobulin polypeptide chains |
| Q48077795 | Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC. |
| Q40429882 | Molecular foundations of cancer: New targets for intervention |
| Q40832210 | Molecular genetic changes in human breast cancer |
| Q38806483 | Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours |
| Q41252914 | Molecular genetics and lymphoproliferative disorders |
| Q40422429 | Molecular genetics of disorders of calcium homeostasis |
| Q37448279 | Molecular genetics of parathyroid disease. |
| Q34195878 | Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance |
| Q43609590 | Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology |
| Q41810203 | Molecular mechanisms of OLIG2 transcription factor in brain cancer. |
| Q40624233 | Molecular mechanisms of parathyroid neoplasia. |
| Q34437592 | Molecular mechanisms of primary hyperparathyroidism |
| Q37039386 | Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy |
| Q40454641 | Molecular pathogenesis of pituitary tumours. |
| Q31889854 | Molecular pathology of parathyroid tumors |
| Q41444722 | Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus |
| Q34215550 | Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia |
| Q40471503 | Multiple endocrine neoplasia type 1 (MEN 1) revisited. |
| Q33851133 | Mutation of cell cycle regulators and their impact on superficial bladder cancer |
| Q36946892 | Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism |
| Q28188807 | Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies |
| Q35798342 | Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. |
| Q90101472 | Neospora caninum Dense Granule Protein 7 Regulates the Pathogenesis of Neosporosis by Modulating Host Immune Response |
| Q36678011 | Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB |
| Q68069200 | New gene in the homologous human 11q13-q14 and mouse 7F chromosomal regions |
| Q56899391 | New nucleotide sequence data on the EMBL File Server |
| Q56899522 | New nucleotide sequence data on the EMBL File Server |
| Q38472480 | New twist in the regulation of cyclin D1. |
| Q40881085 | Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma |
| Q74576344 | Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma |
| Q28567562 | Novel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phas |
| Q36811297 | Nuclear Binding of Purified Retinoblastoma Gene Product Is Determined by Cell Cycle-Regulated Phosphorylation |
| Q37470373 | Nuclear cyclin D1: an oncogenic driver in human cancer |
| Q42590333 | Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. |
| Q67488545 | Oncogenes |
| Q40883891 | Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation. |
| Q36006249 | Oncogenic capacity of the E2F1 gene |
| Q53454693 | Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation. |
| Q28507582 | Oncogenic potential of the DNA replication licensing protein CDT1 |
| Q73689568 | Oncogenic transformation of normal enterocytes by overexpression of cyclin D1 |
| Q35795143 | Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. |
| Q44319784 | Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation |
| Q64064502 | Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway |
| Q73507942 | Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma |
| Q41855173 | Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers |
| Q54987357 | Overexpression of cyclin D1 in rat esophageal carcinogenesis model. |
| Q35923870 | Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line |
| Q41578929 | Overexpression of interleukin-18 protein reduces viability and induces apoptosis of tongue squamous cell carcinoma cells by activation of glycogen synthase kinase-3β signaling |
| Q58001037 | Overlapping morphologic and immunophenotypic profiles in small B-cell lymphoma. A report of two cases |
| Q38175443 | Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present. |
| Q33989869 | Oxidative stress and cell cycle checkpoint function. |
| Q37184060 | P21 and p27: roles in carcinogenesis and drug resistance |
| Q40038649 | PKR and PKR-like endoplasmic reticulum kinase induce the proteasome-dependent degradation of cyclin D1 via a mechanism requiring eukaryotic initiation factor 2alpha phosphorylation |
| Q24560056 | PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma |
| Q41201990 | PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma |
| Q28298193 | PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint |
| Q42702906 | PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers |
| Q39015716 | PTH-C1: a rat continuous cell line expressing the parathyroid phenotype |
| Q42930137 | Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. |
| Q40559871 | Pathogenesis of pituitary Cushing's syndrome. Pituitary versus hypothalamic. |
| Q73498547 | Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid |
| Q57287675 | Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer |
| Q37355688 | Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro |
| Q41077189 | Plant cells contain a novel member of the retinoblastoma family of growth regulatory proteins |
| Q41091749 | Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor |
| Q41367986 | Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation |
| Q34029063 | Possible prognostic significance of p53, cyclin D1 and Ki-67 in the second primary malignancy of patients with double primary malignancies |
| Q39946549 | Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. |
| Q36701076 | Primary structure of the herpesvirus saimiri genome |
| Q36134992 | Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer |
| Q40434039 | Progress against cancer |
| Q35255782 | Progress in molecular biology of breast cancer |
| Q37375698 | Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes |
| Q24321135 | Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells |
| Q55002637 | Quantitative analysis of cyclin D1 messenger RNA expression in head and neck squamous cell carcinomas. |
| Q43572717 | Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma |
| Q36552538 | Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells |
| Q34164600 | Ras-dependent cell cycle commitment during G2 phase |
| Q78854562 | Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma |
| Q92896609 | Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology |
| Q41488826 | Recent insights into the functions of the retinoblastoma susceptibility gene product |
| Q30420795 | Recurrent ZFX mutations in human sporadic parathyroid adenomas |
| Q36090819 | Redundant cyclin overexpression and gene amplification in breast cancer cells |
| Q37279604 | Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression |
| Q41639250 | Regulation of CDK/cyclin complexes during the cell cycle |
| Q36599668 | Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells |
| Q42834597 | Regulation of cyclin D1 by calpain protease |
| Q33635621 | Regulation of hormonal therapy resistance by cell cycle machinery |
| Q41523304 | Relocation and distinct subcellular localization of p34cdc2-cyclin B complex at meiosis reinitiation in starfish oocytes |
| Q35872212 | Repression of cyclin D1 expression does not contribute to initiation or maintenance of cell transformation by adenovirus type 5 E1 |
| Q36654990 | Repression of cyclin D1: a novel function of MYC |
| Q36531419 | Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210 |
| Q37367075 | Retinoid chemoprevention trials: cyclin D1 in the crosshairs |
| Q37827932 | Review article Alterations in cyclin D1, p53, and the cell cycle related elements Implications for distinct genetic pathways of urinary bladder carcinogenesis |
| Q36573600 | Role of cyclins in neuronal differentiation of immortalized hippocampal cells |
| Q53455197 | Role of the INK4a locus in tumor suppression and cell mortality. |
| Q35721985 | Role of transforming growth factor beta in breast carcinogenesis |
| Q36626696 | Signaling pathways that control cell proliferation. |
| Q73048637 | Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features |
| Q45297822 | Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer |
| Q36982125 | Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma |
| Q46117758 | Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1. |
| Q41199433 | Specific transformation abolishes cyclin D1 fluctuation throughout the cell cycle |
| Q73980700 | Sporadic amplification of the insulin receptor gene in human breast cancer |
| Q35761279 | Squamous epithelial proliferation induced by walleye dermal sarcoma retrovirus cyclin in transgenic mice |
| Q59077271 | Starting and stopping |
| Q41252190 | Stem-cell factor regulates the expression of cyclin A and retinoblastoma gene product in the growth and differentiation pathway of human megakaryocytic cells |
| Q24300272 | Structure and expression of the human p58clk-1 protein kinase chromosomal gene |
| Q40814272 | Study on the role of G1 cyclins in Epstein-Barr virus-associated human lymphomas maintained in severe combined immune deficiency (SCID) mice |
| Q42578069 | Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability |
| Q36669107 | Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells |
| Q34061513 | Surgical approaches to primary hyperparathyroidism |
| Q40871675 | Synergistic action of Drosophila cyclins A and B during the G2-M transition |
| Q41990579 | Systematic module approach identifies altered genes and pathways in four types of ovarian cancer |
| Q28082912 | Targeting CDK4 and CDK6: From Discovery to Therapy |
| Q57405732 | The Cell Cycle: A Review |
| Q67900062 | The Cell Cycle: Spinning Farther Afield |
| Q35100242 | The DNA methylome of benign and malignant parathyroid tumors |
| Q40370724 | The Drosophila cyclin D-Cdk4 complex promotes cellular growth |
| Q34057186 | The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues |
| Q36980923 | The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice. |
| Q55237298 | The Positive Nuclear Staining Observed with Monoclonal Antibody against PRAD1/Cyclin D1 Correlates with mRNA Expression in Mantle Cell Lymphoma |
| Q85057853 | The RNA-binding protein La contributes to cell proliferation and CCND1 expression |
| Q40317015 | The Wnt pathway destabilizes adherens junctions and promotes cell migration via β-catenin and its target gene cyclin D1. |
| Q36644993 | The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. |
| Q39914245 | The antiproliferative effect of EPA in HL60 cells is mediated by alterations in calcium homeostasis |
| Q44998272 | The basic helix-loop-helix transcription factor neuroD is expressed in the rod lineage of the teleost retina. |
| Q40733277 | The cell cycle and the retinoblastoma protein family |
| Q35157537 | The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer |
| Q52106307 | The developmental expression of cell cycle regulators in Xenopus laevis. |
| Q73268970 | The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung |
| Q33653192 | The folate receptor as a potential therapeutic anticancer target |
| Q34460347 | The history and future of targeting cyclin-dependent kinases in cancer therapy |
| Q58061470 | The insulin–like growth factor type–2 receptor gene is imprinted in the mouse but not in humans |
| Q40442663 | The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes-a review |
| Q41175188 | The mammalian cell cycle in normal and abnormal growth |
| Q47920723 | The molecular genetics of endocrine tumours |
| Q57538318 | The plant cell cycle in context |
| Q24605485 | The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites |
| Q38473917 | The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma |
| Q36962414 | The retinoblastoma protein physically associates with the human cdc2 kinase |
| Q34088323 | The role and regulation of D-type cyclins in the plant cell cycle |
| Q40790429 | The role of Bcl-2 in the pathogenesis of B chronic lymphocytic leukemia |
| Q74215024 | The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer |
| Q53428840 | The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. |
| Q58068890 | The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma |
| Q34616409 | The role of oncogenes in gastrointestinal cancer |
| Q53396667 | The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. |
| Q38165149 | The role of polo-like kinase 1 in carcinogenesis: cause or consequence? |
| Q41035980 | The role of the insulin-like growth factor system in human cancer |
| Q38398088 | The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells |
| Q33635587 | Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma. |
| Q40351474 | Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression |
| Q33824768 | Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells |
| Q36646526 | Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases |
| Q40959643 | Transgenic mouse models of breast cancer |
| Q41202018 | Translocation t(8;16)(p11;p13) in acute non-lymphocytic leukemia: report on two new cases and review of the literature. |
| Q42856274 | Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor |
| Q36183682 | Tumor suppressor genes in the cell cycle |
| Q30499489 | Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers |
| Q64109942 | Turning Point in the Treatment of Mantle Cell Lymphoma |
| Q34346963 | Ubiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibility |
| Q95824195 | Uncoupling of membrane ruffling and pinocytosis during Ras signal transduction |
| Q70565444 | Unexpected Prad-1 amplification in multiple simultaneous localisations of squamous cell carcinoma of the head and neck |
| Q35583393 | Update on genetic and clinical aspects of primary hyperparathyroidism |
| Q33860808 | Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer |
| Q40675128 | Viral transformation of human T lymphocytes. |
| Q41431627 | Virus-encoded cyclin |
| Q33785258 | Walleye retroviruses associated with skin tumors and hyperplasias encode cyclin D homologs. |
| Q34362269 | Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas |
| Q41024260 | Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia |
| Q37024214 | Zebrafish cyclin Dx is required for development of motor neuron progenitors, and its expression is regulated by hypoxia-inducible factor 2α. |
| Q73826933 | [Cytogenetic abnormalities in malignant lymphoma and multiple myeloma] |
| Q24555683 | cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA, and activate DNA replication |
| Q35933286 | cdc2 phosphorylation is required for its interaction with cyclin. |
| Q28145650 | cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain |
| Q45920518 | miR-148b Regulates Proliferation and Differentiation of Neural Stem Cells via Wnt/β-Catenin Signaling in Rat Ischemic Stroke Model. |
| Q36619103 | miR-150 inhibits terminal erythroid proliferation and differentiation |
| Q53098748 | miR-216a-3p Inhibits the Proliferation, Migration, and Invasion of Human Gastric Cancer Cells via Targeting RUNX1 and Activating the NF-κB Signaling Pathway. |
| Q52716876 | miRNA‑222 promotes liver cancer cell proliferation, migration and invasion and inhibits apoptosis by targeting BBC3. |
| Q74454269 | p27(kip1) and Other Cell-Cycle Protein Expression in Normal and Neoplastic Endocrine Tissues |
| Q40020773 | p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression |
| Q42755072 | p53 alterations in human squamous cell carcinomas and carcinoma cell lines |
| Q54964052 | p53 mutation in B-cell lymphoid neoplasms with reference to oncogene rearrangements associated with chromosomal translocations. |
| Q89896871 | p53, Cyclin-D1, β-catenin, APC and c-myc in Tumor Tissue from Colorectal and Gastric Cancer Patients with Suspected Lynch Syndrome by the Bethesda Criteria |
| Q47449243 | p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma |
| Q74453838 | p53/MDM2 Pathway Aberrations in Parathyroid Tumors: p21(WAF-1) and MDM2 Are Frequently Overexpressed in Parathyroid Adenomas |
| Q39517920 | shRNA targeting PLCε inhibits bladder cancer cell growth in vitro and in vivo |
Search more.